We are live on
!
Find out more
TA
Tiedemann Advisors Portfolio holdings
AUM
$2.33B
1-Year Est. Return
15.56%
This Fund
S&P 500
This Quarter
Est. Return
+6.03%
1 Year Est. Return
+15.56%
3 Year Est. Return
+31.46%
5 Year Est. Return
+38.22%
10 Year Est. Return
+101.99%
AUM
$2.09B
AUM Growth
+$3.38M
(+0.16%)
Cap. Flow
+$5.34B
Cap. Flow
% of AUM
256.1%
Top 10 Holdings %
Top 10 Hldgs %
46.59%
Holding
327
New
28
Increased
70
Reduced
169
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$19.8M |
| 2 |
LPT
Liberty Property Trust
LPT
|
+$18.7M |
| 3 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$17.7M |
| 4 |
iShares Gold Trust
IAU
|
+$8.8M |
| 5 |
Relmada Therapeutics
RLMD
|
+$8.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Energy Transfer Partners
ET
|
+$23.5M |
| 2 |
TGE
Tallgrass Energy, LP Class A Shares
TGE
|
+$9.25M |
| 3 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.03M |
| 4 |
First Trust North American Energy Infrastructure Fund
EMLP
|
+$7.84M |
| 5 |
iShares Latin America 40 ETF
ILF
|
+$6.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 15.93% |
| 2 | Technology | 8.29% |
| 3 | Utilities | 6.16% |
| 4 | Communication Services | 3.32% |
| 5 | Financials | 2.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Southern Company
SO
$108B
| $389K | 0.02% |
6,110
-1,112
| -15% | -$68.9K |
|
227
TransDigm Group
TDG
$70.7B
| $368K | 0.02% |
658
+147
| +29% | +$80.5K |
|
228
CSX Corp
CSX
$94B
| $363K | 0.02% |
15,051
+534
| +4% | +$12.6K |
|
229
State Street Industrial Select Sector SPDR ETF
XLI
$32.2B
| $363K | 0.02% |
4,457
+122
| +3% | +$9.74K |
|
230
Zoetis
ZTS
$32.7B
| $362K | 0.02% |
2,729
-694
| -20% | -$86.2K |
|
231
Astrana Health
ASTH
$1.81B
| $359K | 0.02% |
19,500
| – | – |
|
232
Edwards Lifesciences
EW
$49.4B
| $357K | 0.02% |
4,584
-1,482
| -24% | -$116K |
|
233
Pembina Pipeline
PBA
$29.3B
| $349K | 0.02% |
9,392
-200
| -2% | -$7.15K |
|
234
iShares US Real Estate ETF
IYR
$4.75B
| $345K | 0.02% |
3,713
| – | – |
|
235
PayPal
PYPL
$49.9B
| $341K | 0.02% |
3,146
-1,920
| -38% | -$200K |
|
236
JD.com
JD
$43.5B
| $338K | 0.02% |
9,586
| – | – |
|
237
Coastal Financial
CCB
$1.08B
| $332K | 0.02% |
20,158
-959
| -5% | -$15.5K |
|
238
BP
BP
$112B
| $319K | 0.02% |
8,465
-24,820
| -75% | -$942K |
|
239
iShares Floating Rate Bond ETF
FLOT
$10.2B
| $315K | 0.02% |
6,177
+846
| +16% | +$43.1K |
|
|
GRDX
240
GridAI Technologies Corp
GRDX
$18.3M
| $314K | 0.02% |
2
+1
| +100% | +$93.2K |
|
|
NVO
241
Novo Nordisk
NVO
$228B
| $311K | 0.01% |
10,732
-1,434
| -12% | -$39.7K |
|
242
Progressive
PGR
$128B
| $303K | 0.01% |
4,180
-7,813
| -65% | -$563K |
|
243
iShares US Aerospace & Defense ETF
ITA
$14B
| $302K | 0.01% |
2,710
-7,730
| -74% | -$868K |
|
|
RDS.A
244
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $302K | 0.01% |
5,111
-926
| -15% | -$54.1K |
|
245
Regeneron Pharmaceuticals
REGN
$72.9B
| $299K | 0.01% |
795
-22
| -3% | -$7.4K |
|
246
GE Aerospace
GE
$364B
| $297K | 0.01% |
5,349
-1,897
| -26% | -$98K |
|
247
Medtronic
MDT
$112B
| $297K | 0.01% |
2,610
-372
| -12% | -$40.8K |
|
248
iShares S&P 100 ETF
OEF
$19.5B
| $294K | 0.01% |
2,040
-17
| -0.8% | -$2.33K |
|
249
iShares Select U.S. REIT ETF
ICF
$2.13B
| $290K | 0.01% |
4,958
-84
| -2% | -$4.94K |
|
250
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.61B
| $285K | 0.01% |
5,939
| – | – |
|
Similar funds
API
SCH
PWAG
CS
IWP
MAM
FBA
FDCC
Tiedemann Advisors's Q4 2019 Portfolio in Review
As of Q4 2019, Tiedemann Advisors held 327 positions worth $2.09B, up 0.16% from $2.08B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Tiedemann Advisors deployed $5.34B of net new capital in Q4 2019, opening 28 new positions and adding to 70 existing holdings. Its largest new stake was Relmada Therapeutics: 282,592 shares worth $11M.
By sector, the portfolio is most concentrated in Energy at 16% of assets, down from 19% a quarter earlier, followed by Technology and Utilities.
On the sell side, the largest reduction was Energy Transfer Partners, an estimated $23.5M trimmed.
- Tiedemann Advisors's largest Q4 2019 buy was Relmada Therapeutics: 282,592 shares worth $11M.
- Tiedemann Advisors added most to Vanguard FTSE Developed Markets ETF in Q4 2019, an estimated $19.8M increase.
- Tiedemann Advisors's biggest Q4 2019 reduction was Energy Transfer Partners, cutting an estimated $23.5M.
- Tiedemann Advisors fully exited Tallgrass Energy, LP Class A Shares in Q4 2019, selling an estimated $9.25M.
- Tiedemann Advisors's ten largest holdings make up 47% of its $2.09B portfolio in Q4 2019.
- Tiedemann Advisors opened 28 new positions and closed 29 in Q4 2019.
- Tiedemann Advisors's portfolio value rose 0.16% quarter-over-quarter to $2.09B.
Based on Tiedemann Advisors's 13F filing for Q4 2019, filed 12 Feb 2020.